<code id='17C3EA60D1'></code><style id='17C3EA60D1'></style>
    • <acronym id='17C3EA60D1'></acronym>
      <center id='17C3EA60D1'><center id='17C3EA60D1'><tfoot id='17C3EA60D1'></tfoot></center><abbr id='17C3EA60D1'><dir id='17C3EA60D1'><tfoot id='17C3EA60D1'></tfoot><noframes id='17C3EA60D1'>

    • <optgroup id='17C3EA60D1'><strike id='17C3EA60D1'><sup id='17C3EA60D1'></sup></strike><code id='17C3EA60D1'></code></optgroup>
        1. <b id='17C3EA60D1'><label id='17C3EA60D1'><select id='17C3EA60D1'><dt id='17C3EA60D1'><span id='17C3EA60D1'></span></dt></select></label></b><u id='17C3EA60D1'></u>
          <i id='17C3EA60D1'><strike id='17C3EA60D1'><tt id='17C3EA60D1'><pre id='17C3EA60D1'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:48754
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          What drug price negotiations mean for Medicare Part D
          What drug price negotiations mean for Medicare Part D

          AdobeAftertherecentannouncementofthefirst10drugsselectedforMedicarepricenegotiation,muchhasbeendiscu

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          How to fix cancer clinical trials' diversity problem

          Clockwisefromtopleft:STAT'sNicholasSt.Fleur(moderator);JudySewards,headofclinicaltrialexperienceatPf